EU ramps up supply of COVID-19 vaccine, drugs

The European Commission has taken its advance orders for potential COVID-19 vaccines to more than 1.1 billion, after signing a supply deal for up to 400 million doses of Johnson & Johns

Life science leaders sign new ‘Biotech Social Pact’ for Euro...

The signatories of a new Biotech Social Pact with Europe and p

Alnylam’s Anant Murthy on making it as a US biotech in Europ...

Alnylam’s European head of market access and GM of mid-size markets, Anant Murthy, shares his perspective on how a US biotech can adapt to the many unique challenges of the EU market.

CureVac claims €75m in EU funding for mRNA COVID-19 vaccine

German vaccine firm CureVac has been awarded a €75 million loan from the European Investment Bank to boost its manufacturing capacity for its potential COVID-19 vaccine.

Pfizer’s EU Vyndaqel okay ‘sets up $1.5bn sales next year’

The great regulatory catch-up

Medical device manufacturers have a lot to learn from the pharmaceutical sector which, for well over a decade, has been subject to the sorts of rigorous electronic reporting standards soon